MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q1
hinzugefügt 29.06.2022
Takeda Pharmaceutical Company Limited Kurshistorie 2011-2026 | TAK
Kurshistorie Jährlich Takeda Pharmaceutical Company Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 13.6 | 18.2 | 18.8 | 15.3 | 25 | 17.7 | 20.6 | 16.6 | 17.8 | 16.5 | 15.7 |
Alle Zahlen in JPY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 25 | 13.6 | 17.8 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ADMA Biologics
ADMA
|
15.9 | $ 16.62 | 1.47 % | $ 3.96 B |  USA |
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
ANI Pharmaceuticals
ANIP
|
61.9 | $ 77.07 | 1.27 % | $ 1.49 B | USA |
 |
Apellis Pharmaceuticals
APLS
|
22 | $ 20.12 | -0.2 % | $ 2.54 B | USA |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.81 | 2.62 % | $ 4.42 M |  China |
 |
Graybug Vision
GRAY
|
0.44 | - | -11.23 % | $ 9.65 M | USA |
 |
Axsome Therapeutics
AXSM
|
174 | $ 164.87 | 0.5 % | $ 8.2 B | USA |
 |
AbCellera Biologics
ABCL
|
3.22 | $ 3.72 | 0.13 % | $ 1.11 B |  Canada |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | China |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
BioLineRx Ltd.
BLRX
|
2.65 | $ 2.84 | 1.07 % | $ 908 M |  Israel |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
3.54 | - | - | $ 521 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
61 | $ 61.12 | 4.43 % | $ 11.7 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Burford Capital Limited
BUR
|
10.6 | $ 8.38 | -1.99 % | $ 1.39 B | Britain |
 |
Cabaletta Bio
CABA
|
17.5 | $ 3.42 | 5.08 % | $ 3.99 M | USA |
 |
BridgeBio Pharma
BBIO
|
68.4 | $ 67.08 | 3.95 % | $ 12.8 B | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
CymaBay Therapeutics
CBAY
|
32.3 | - | - | $ 3.45 B | USA |
 |
Avid Bioservices
CDMO
|
6.7 | - | - | $ 789 M | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Codexis
CDXS
|
3.97 | $ 1.1 | 11.73 % | $ 80.7 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
4.04 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
0.43 | - | -16.75 % | $ 25.8 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Clovis Oncology
CLVS
|
2.04 | - | -7.23 % | $ 13 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
2.44 | - | - | $ 231 M | USA |
 |
Coherus BioSciences
CHRS
|
2.22 | $ 1.8 | 8.79 % | $ 169 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
CTI BioPharma Corp.
CTIC
|
4.8 | - | - | $ 1.2 B | USA |
 |
CohBar
CWBR
|
1.83 | - | -15.44 % | $ 2.2 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
0.25 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
4.9 | - | -4.36 % | $ 27 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
14.1 | - | - | $ 2.18 B | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Capricor Therapeutics
CAPR
|
5.8 | $ 26.34 | 1.93 % | $ 705 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Certara
CERT
|
6.72 | $ 7.25 | 0.14 % | $ 1.16 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Champions Oncology
CSBR
|
7.75 | $ 6.05 | 0.83 % | $ 82.6 M | USA |